JPRN-UMIN000003091已完成2 期
A pilot study of neoajuvant fluorouracil, epirubicin and cyclophosphamide followed by paclitaxel plus high dose toremifene in women with node positive or high-risk breast cancer. - Neoajuvant FEC followed by paclitaxel plus high dose toremifene in women with node positive or high-risk breast cancer.
Department of Breast Surgery, Fukushima Medical University School of Medicine0 个研究点目标入组 20 人开始时间: 2010年1月26日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 30years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1.Case with active other malignancies 2.Case with past history of drug allergy or hypersensitivity 3.Case during pregnancy or lactation 4.Case with adverse myelosuppression 5.Case with infectious disease 6.Case with inflammatory breast cancer 7.Case with metastatic breast cancer 8.Case judged inappropriate by physicians
研究者
相似试验
已完成
1 期
Phase I Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan(FOLFOXIRI) for Metastatic or Reccurence Colorectal CancerColorectal CancerJPRN-UMIN000000883Department of Clinical Oncology, Conprehensive Cancer Center, Saitama Medical University International Medical Center10
已完成
不适用
A randomised trial of adjuvant 5-fluorouracil, leucovorin and radiotherapy in colorectal adenocarcinomaColon, Rectal cancer1. Malignant neoplasm of colon2. Malignant neoplasm of rectumCancerISRCTN88796215Wyeth-Lederle Ltd (UK)
已完成
2 期
Effects of fluoride and laser on streptococcus mutansIRCT2017061817756N20Vice-Chancellery for Research and Technology of Birjand University of Medical Sciences36
已完成
1 期
Phase I Study of Neoadjuvant Radiotherapy With 5-Fluorouracil for Rectal CancerMucinous Adenocarcinoma of the RectumRecurrent Rectal CancerSignet Ring Adenocarcinoma of the RectumRectal AdenocarcinomaStage IIA Rectal CancerStage IIB Rectal CancerStage IIC Rectal CancerStage IIIA Rectal CancerStage IIIB Rectal CancerStage IIIC Rectal CancerNCT02270606Virginia Commonwealth University14
招募中
2 期
A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with trastuzumab for HER2-positive breast cancerBreast cancerJPRN-UMIN000013886Tokyo Women's Medical University30